EnGeneIC
www.engeneic.comEngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.
Read more
EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.
Read more
Country
Industry
Employees
11-50
Founded
2001
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Joint - Chief Executive Officer and Director
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Senior Finance Manager
Email ****** @****.comPhone (***) ****-****Senior Scientist
Email ****** @****.comPhone (***) ****-****
Technologies
(17)
Reach decision makers at EnGeneIC
Free credits every month!
EnGeneIC FAQ
Australia
Biotechnology Research
We'll help you understand if Lusha can solve your business needs.
